Results 241 to 247 of about 9,787 (247)

Human Immunodeficiency Virus and Latency Reversing Agents A Path to Cure?

2017
Background: Human immunodeficiency virus (HIV), as its namesake implies, is a virus that ultimately causes a deficient immune system that can lead to Acquired Immune Deficiency Syndrome (AIDS). Since the discovery of this cytopathic virus in 1983, there have been many scientific advances in regards to its identification and treatment.
openaire   +1 more source

Synthesis and Biological Evaluation of Simplified Ansellone Analogues with Lipophilic Side Chains as HIV Latency‐Reversing Agents

Chemistry - A European Journal, 2023
Mitsuhiro Arisawa, Kenichi Murai
exaly  

Potential HIV latency-reversing agents with STAT1-activating activity from the leaves of Wikstroemia chamaedaphne

Phytochemistry, 2022
Shi-Fei Li, Wen-Hao Wang, Liwei Zhang
exaly  

HIV‐1 infection and latency‐reversing agents bryostatin‐1 and JQ1 disrupt amyloid beta homeostasis in human astrocytes

Glia, 2020
Alize Proust, Corinne Barat, Michel J Tremblay   +2 more
exaly  

New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo

Nature Medicine, 2014
C Korin Bullen, Gregory M Laird, Christine M Durand   +2 more
exaly  

Ex vivo model of HIV latency to screen latency-reversing agents

Science-Business eXchange, 2014
openaire   +1 more source

Synthesis and Biological Evaluation of Chalcone Analogues as HIV Latency Reversing Agents

Journal of Pharmacology & Pharmaceutical Research
openaire   +1 more source